Coherus BioSciences Inc (CHRS)
0.67
-0.05
(-7.33%)
USD |
NASDAQ |
Nov 04, 16:00
0.6701
0.00 (0.00%)
Pre-Market: 08:48
Coherus BioSciences Max Drawdown (5Y): 96.80% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 96.80% |
| September 30, 2024 | 95.60% |
| August 31, 2024 | 94.50% |
| July 31, 2024 | 94.36% |
| June 30, 2024 | 93.20% |
| May 31, 2024 | 93.20% |
| April 30, 2024 | 93.20% |
| March 31, 2024 | 93.20% |
| February 29, 2024 | 93.20% |
| January 31, 2024 | 93.20% |
| December 31, 2023 | 93.20% |
| November 30, 2023 | 93.20% |
| October 31, 2023 | 88.70% |
| September 30, 2023 | 84.00% |
| August 31, 2023 | 83.78% |
| July 31, 2023 | 83.78% |
| June 30, 2023 | 83.78% |
| May 31, 2023 | 82.50% |
| April 30, 2023 | 77.63% |
| March 31, 2023 | 77.63% |
| February 28, 2023 | 77.63% |
| January 31, 2023 | 77.63% |
| December 31, 2022 | 77.63% |
| November 30, 2022 | 77.63% |
| October 31, 2022 | 77.63% |
| Date | Value |
|---|---|
| September 30, 2022 | 77.63% |
| August 31, 2022 | 77.71% |
| July 31, 2022 | 77.71% |
| June 30, 2022 | 77.71% |
| May 31, 2022 | 77.71% |
| April 30, 2022 | 77.71% |
| March 31, 2022 | 77.71% |
| February 28, 2022 | 77.71% |
| January 31, 2022 | 77.71% |
| December 31, 2021 | 77.71% |
| November 30, 2021 | 77.71% |
| October 31, 2021 | 77.71% |
| September 30, 2021 | 77.71% |
| August 31, 2021 | 77.71% |
| July 31, 2021 | 77.71% |
| June 30, 2021 | 77.71% |
| May 31, 2021 | 77.71% |
| April 30, 2021 | 77.71% |
| March 31, 2021 | 77.71% |
| February 28, 2021 | 77.71% |
| January 31, 2021 | 77.71% |
| December 31, 2020 | 77.71% |
| November 30, 2020 | 77.71% |
| October 31, 2020 | 77.71% |
| September 30, 2020 | 77.71% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
77.63%
Minimum
Sep 2022
96.80%
Maximum
Oct 2024
81.61%
Average
77.71%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Repligen Corp | 64.79% |
| Evoke Pharma Inc | 99.53% |
| Personalis Inc | 98.18% |
| Maravai LifeSciences Holdings Inc | -- |
| Tempus AI Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -58.04 |
| Beta (5Y) | 0.6926 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 63.16% |
| Historical Sharpe Ratio (5Y) | -0.7773 |
| Historical Sortino (5Y) | -1.260 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.16% |